These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 28270604)

  • 1. Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids.
    Fumagalli A; Drost J; Suijkerbuijk SJ; van Boxtel R; de Ligt J; Offerhaus GJ; Begthel H; Beerling E; Tan EH; Sansom OJ; Cuppen E; Clevers H; van Rheenen J
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2357-E2364. PubMed ID: 28270604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis.
    Fujii M; Shimokawa M; Date S; Takano A; Matano M; Nanki K; Ohta Y; Toshimitsu K; Nakazato Y; Kawasaki K; Uraoka T; Watanabe T; Kanai T; Sato T
    Cell Stem Cell; 2016 Jun; 18(6):827-838. PubMed ID: 27212702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
    Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
    Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A surgical orthotopic organoid transplantation approach in mice to visualize and study colorectal cancer progression.
    Fumagalli A; Suijkerbuijk SJE; Begthel H; Beerling E; Oost KC; Snippert HJ; van Rheenen J; Drost J
    Nat Protoc; 2018 Feb; 13(2):235-247. PubMed ID: 29300390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF
    Reischmann N; Andrieux G; Griffin R; Reinheckel T; Boerries M; Brummer T
    Oncogene; 2020 Sep; 39(38):6053-6070. PubMed ID: 32792685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
    Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal-induced L1CAM/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids.
    Cave DD; Hernando-Momblona X; Sevillano M; Minchiotti G; Lonardo E
    Theranostics; 2021; 11(12):5686-5699. PubMed ID: 33897875
    [No Abstract]   [Full Text] [Related]  

  • 9. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.
    Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T
    Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiated cancer cell-originated lactate promotes the self-renewal of cancer stem cells in patient-derived colorectal cancer organoids.
    Zhao H; Yan C; Hu Y; Mu L; Liu S; Huang K; Li Q; Li X; Tao D; Qin J
    Cancer Lett; 2020 Nov; 493():236-244. PubMed ID: 32898601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
    Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
    EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer.
    O'Rourke KP; Loizou E; Livshits G; Schatoff EM; Baslan T; Manchado E; Simon J; Romesser PB; Leach B; Han T; Pauli C; Beltran H; Rubin MA; Dow LE; Lowe SW
    Nat Biotechnol; 2017 Jun; 35(6):577-582. PubMed ID: 28459450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF-β.
    Wiener Z; Band AM; Kallio P; Högström J; Hyvönen V; Kaijalainen S; Ritvos O; Haglund C; Kruuna O; Robine S; Louvard D; Ben-Neriah Y; Alitalo K
    Proc Natl Acad Sci U S A; 2014 May; 111(21):E2229-36. PubMed ID: 24825889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
    Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling Colorectal Cancer Progression Through Orthotopic Implantation of Organoids.
    de Sousa E Melo F; Harnoss JM; Kljavin N; Scott R; Sohn C; Leong KG; de Sauvage FJ
    Methods Mol Biol; 2020; 2171():331-346. PubMed ID: 32705654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An In Vivo Metastasis Model Using Genotype-Defined Tumor Organoids.
    Morita A; Nakayama M; Oshima H; Oshima M
    Methods Mol Biol; 2024; 2828():57-68. PubMed ID: 39147970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 20. Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.
    Neumann J; Wehweck L; Maatz S; Engel J; Kirchner T; Jung A
    Virchows Arch; 2013 Oct; 463(4):509-23. PubMed ID: 23934607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.